Ultimately, pre-clinical xenograft tumor model showed that the knockdown of CD27-AS1-208 expression resulted in significant suppression of tumor growth compared with the control, as revealed by impaired volume and weight of CD27-AS1-208- knockdown tumors (Figures 5A–C). This evidence concerns the gene CD27 and neoplasm.